Arcturus Therapeutics Holdings Inc.
ARCT
$12.23
-$0.41-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.08M | -30.01M | -6.90M | -17.22M | -26.82M |
| Total Depreciation and Amortization | 801.00K | 819.00K | 912.00K | 909.00K | 904.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.68M | 8.81M | 9.70M | 9.81M | 10.14M |
| Change in Net Operating Assets | -28.55M | 20.09M | -27.47M | -23.65M | 10.22M |
| Cash from Operations | -35.14M | -284.00K | -23.76M | -30.14M | -5.56M |
| Capital Expenditure | -137.00K | 0.00 | -80.00K | -328.00K | -240.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -137.00K | 0.00 | -80.00K | -328.00K | -240.00K |
| Total Debt Issued | 15.00M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 195.00K | 134.00K | 693.00K | 2.40M | 2.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.20M | 134.00K | 693.00K | 2.40M | 2.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.08M | -150.00K | -23.15M | -28.07M | -3.61M |